Genmab — Juni 2020

[StockBull]

nyt TA signal https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/84651_nyt_genmab_signal.JPG

[Bulder]

I suppose the expansion part will be ready for ASH

[Bulder]

If not CMD 30/11

[gentogen]

Med en rising wedge går jeg ud fra, at vi snart kan supplere billigt igen - eller hvordan er det nu med det

[Vitus]

Markedet og Genmab faldt tilbage den sidste halve time...

[Legolas23]

Sikker

[nohope]

Lille tab i fri pf, større gevinst i pension pf. Ærgerligt det faldt tilbage mod luk.

[Solsen]

Heller ikke vin i aften nohope. Du bliver rig af alt det vin du sparer

[Helge_LarsenPI-redaktør]

Genmabs poster discussions on epcoritamab (DuoBody-CD3xCD20), HexaBody-CD38, and DuoHexaBody-CD37 are now
available to view on demand. https://ehaweb.org/congress/eha25/virtual/

[Solsen]

Gode data fra vores venner Abbvie i psoriasis https://finance.yahoo.com/news/abbvie-presents-breaking-data-showing-190200489.html

[Jazzz]

Nogen der forstår baggrunden for at HSBC år efter år sætter Genmab så lavt.. mærkeligt og helt ude af trit...

[bibob]

Dr Hari on the role of MRD in MM. https://www.onclive.com/view/dr-hari-on-the-role-of-mrd-in-multiple-myeloma?eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

[E_L]

Adding Daratumumab to CyBorD Improves Outcomes for AL Amyloidosis https://www.onclive.com/view/adding-daratumumab-to-cybord-improves-outcomes-for-al-amyloidosis

[E_L]

HexaBody Technology Platform https://www.youtube.com/watch?v=33LiakTF9cs

[E_L]

this is the small biotech fund investment
i referred to a few days ago https://twitter.com/Genmab/status/1271505500165885952

[E_L]

EHA: Johnson & Johnson's Darzalex branches out beyond myeloma with AL amyloidosis win https://www.fiercepharma.com/pharma/eha-johnson-johnson-s-darzalex-branches-out-beyond-myeloma-al-amyloidosis-win?utm_source=dlvr.it&utm_medium=twitter

[GeorgeBest]

Interessant kommentar fra Martin Hutchings „CR is almost surely underestimated, particularly in FL“ https://twitter.com/dochutchings/status/1271521705400377346?s=21

[GeorgeBest]

Showing examples of Genmab's bispecific antibody technology by Janssen https://twitter.com/raintank2010/status/1271708344965754881?s=21

[Bulder]

Ja, det bliver spændende at følge om epco kan rette op på efterslæbet i CR ift glofitamab. Men positivt, at epco's mildhed gør det til en velegnet combo-partner.

[GeorgeBest]

poster on DuoHexaBody-CD37 https://twitter.com/genmab/status/1271765526268776449?s=21